Entecavir
NDC 61442-311, Entecavir, tablet, from Carlsbad Technology, Inc..
- Product NDC
- 61442-311
- Status
- Listed
- Labeler
- Carlsbad Technology, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208195
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61442-311 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENTECAVIR.5 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61442-311-30 | 61442031130 | 30 TABLET in 1 BOTTLE, PLASTIC (61442-311-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a905283-0057-a7dd-e063-6394a90a1909NADAC price for package 61442031130
GET /v1/drugs/nadac/61442031130
Use it
Look up 61442-311 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61442-311 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61442-311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.